Samantha McLemore - Patient Capital Management,
Holding/activity history for Precigen Inc. (PGEN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 17,817,387 | 2.57 | Reduce 4.58% | 0.14 | $3.87 | $68,953,288 | SEC |
| 2025 Q4 | 18,673,466 | 3.01 | Reduce 29.43% | 1.02 | $4.18 | $78,055,089 | SEC |
| 2025 Q3 | 26,460,848 | 3.48 | Add 62.65% | 1.34 | $3.29 | $87,056,189 | SEC |
| 2025 Q2 | 16,268,741 | 1.04 | Reduce 6.35% | 0.08 | $1.42 | $23,101,613 | SEC |
| 2025 Q1 | 17,372,301 | 1.33 | Reduce 2.85% | 0.03 | $1.49 | $25,884,728 | SEC |
| 2024 Q4 | 17,881,246 | 0.92 | Reduce 0.31% | <0.01 | $1.12 | $20,026,995 | SEC |
| 2024 Q3 | 17,937,694 | 0.83 | Reduce 1.30% | 0.02 | $0.95 | $16,988,789 | SEC |
| 2024 Q2 | 18,174,658 | 1.53 | Add 4.13% | 0.06 | $1.58 | $28,715,960 | SEC |
| 2024 Q1 | 17,453,455 | 1.23 | Add 9.20% | 0.10 | $1.45 | $25,307,509 | SEC |
| 2023 Q4 | 15,983,700 | 1.14 | Add 16.22% | 0.16 | $1.34 | $21,418,157 | SEC |
| 2023 Q3 | 13,753,176 | 1.15 | Add 22.32% | 0.21 | $1.42 | $19,529,510 | SEC |
| 2023 Q2 | 11,243,560 | 0.72 | Add 668.13% | 0.63 | $1.15 | $12,930,093 | SEC |
| 2023 Q1 | 1,463,760 | 0.70 | Add 83.38% | 0.32 | $1.06 | $1,551,586 | SEC |
| 2022 Q4 | 798,200 | 0.60 | Add 167.67% | 0.38 | $1.52 | $1,213,264 | SEC |
| 2022 Q3 | 298,200 | 0.32 | $2.12 | $632,000 | SEC | ||
| 2022 Q2 | 298,200 | 0.20 | $1.34 | $400,000 | SEC | ||
| 2022 Q1 | 298,200 | 0.25 | $2.11 | $629,000 | SEC | ||
| 2021 Q4 | 298,200 | 0.45 | $3.71 | $1,106,000 | SEC |